Outpatient and hybrid delivery of cellular therapies a US perspective – IMS 2025
Published:
In our experience at Emory Winship Cancer Institute, we have identified a few essential pieces that should be evaluated as part of outpatient cell therapy program development. Institutional considerations, including what 24/7 access looks like, must be established. For example, we have an oncology-dedicated 24-hour care unit that provides an alternative to the emergency department. This resource is unique to our center, but it is not necessary.
Sign up and become a member of the Myeloma UK HCP Hub
Access exclusive content like this and join in the conversation.
Already have an account?